Table 1.
Summary of baseline demographics
| Ranirestat (n = 268) | Placebo (n = 269) | |
|---|---|---|
| Age at informed consent (years) | 62.1 ± 9.1 | 60.9 ± 9.0 |
| Male sex | 185 (69.0) | 178 (66.2) |
| BMI (kg/m2) | 24.99 ± 3.96 | 25.55 ± 4.14 |
| Type 2 diabetes | 252 (94.0) | 253 (94.1) |
| Diabetes duration (years) | 15.0 ± 9.0 | 14.7 ± 8.3 |
| DPN duration (years) | 6.1 ± 4.9 | 5.8 ± 4.7 |
| HbA1c (%) | 7.46 ± 0.67 | 7.51 ± 0.77 |
Data are n (%) for sex and type 2 diabetes, and mean ± standard deviation for other parameters. BMI, body mass index; DPN, diabetic polyneuropathy; HbA1c, glycated hemoglobin.